Use of inhibitors and antisense oligonucleotides of BTK for treating proliferative mastocytosis
US8227433B2 · kind B2 · utility
1Cited by
2References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 3, 2004 |
| Grant date | Jul 24, 2012 |
| Priority date | — |
| Expiry date | Aug 29, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/10001
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for treating proliferative mastocytosis comprising administering a Bruton tyrosine kinase (BTK) inhibitor, a BTK antisense to a mammal in need of such treatment. The invention is more particularly suited for treating category II, III and IV mastocytosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.